Evidence map›Paper›PMID 32737764›Full record

ArticleMolecular neurobiology2020

Brain Dicer1 Is Down-Regulated in a Mouse Model of Alzheimer's Disease Via Aβ42-Induced Repression of Nuclear Factor Erythroid 2-Related Factor 2.

Yan Wang, Meiling Lian, Jing Zhou, Shengzhou Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yan WangSchool of Optometry and Ophthalmology and the Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Meiling LianSchool of Optometry and Ophthalmology and the Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Jing ZhouSchool of Optometry and Ophthalmology and the Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Shengzhou WuSchool of Optometry and Ophthalmology and the Eye Hospital, Wenzhou Medical University, Wenzhou, China. wszlab@mail.eye.ac.cn.ORCID https://orcid.org/0000-0003-1154-2369
Wenzhou Medical University · CN

Funding

Natural Science Foundation of Zhejiang Province LY18H120003Wenzhou Medical University QTJ10001
6 · The paper itself

Abstract

Dicer1 is a microRNA-processing enzyme which plays critical roles in neuronal survival and neuritogenesis. Dicer1 deletion induces neurodegeneration or degeneration in retinal pigment epithelium, which is associated with oxidative stress. Oxidative stress is thought to be central in the pathogenesis of Alzheimer's disease (AD). Therefore, we hypothesize that Dicer1 may play roles in AD. Using immunoblotting and quantitative real-time PCR, Dicer1 protein and mRNA were reduced in the hippocampi of the AD mouse model APPswe/PSEN1dE9 compared with littermate controls. SiRNA-mediated Dicer1 knockdown induced oxidative stress and apoptosis and reduced mitochondrial membrane potential in cultured neurons. Chronic Aβ42 exposure decreased Dicer1 and nuclear factor erythroid 2-related factor 2 (Nrf2) which were reversed by N-acetyl-cystein. Nrf2 overexpression increased Dicer1 mRNA and protein and reverted the Aβ42-induced Dicer1 reduction. We further cloned Dicer1 promoter variants harboring the Nrf2-binding site, the antioxidant response elements (ARE), into a luciferase reporter and found that simultaneous transfection of Nrf2-expressing plasmid increased luciferase expression from these promoter constructs. ChIP assays indicated that Nrf2 directly interacted with the ARE motifs in the Dicer1 promoter. Furthermore, Dicer1 overexpression in cultured neurons reverted Aβ42-induced neurite deficits. Notably, injection of Dicer1-expressing adenovirus into the hippocampus of the mice significantly improved spatial learning. Altogether, we found novel roles of Dicer1 in AD and a novel regulatory pathway for Dicer1. These results suggest that Dicer1 is a target in AD therapy, especially at the early stage of this disorder. In this study, we found that Dicer1 was reduced in the brain of AD mice which is the first report to examine Dicer1 in AD. We further found (i) that Aβ42 exposure decreased Dicer1 via attenuating Nrf2-ARE signaling and (ii) injection of Dicer1-expressing adenovirus into the hippocampus of the AD mice significantly improved spatial learning. Altogether, we found novel roles of Dicer1 in AD and a novel regulatory pathway for Dicer1. This study may open new avenues for investigating potential pathognomonics and pathogenesis in AD.

Indexed as

AcetylcysteineAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAntioxidant Response ElementsApoptosisBrainCaspase 3DEAD-box RNA HelicasesDisease Models, AnimalDown-RegulationFemaleGene Knockdown TechniquesHippocampusHumansMaleAcetylcysteineAmyloid beta-Peptidesamyloid beta-protein (1-42)Caspase 3DEAD-box RNA HelicasesDicer1 protein, mouseNF-E2-Related Factor 2Peptide FragmentsPresenilin-1Reactive Oxygen SpeciesRibonuclease IIIAlzheimer’s diseaseAntioxidant response elementAPPswe/PSEN1dE9 miceDicer1Gene regulationHippocampusNeurodegenerationNeurotoxicityNrf2Oxidative stress

Identifiers

PMID32737764
OpenAlexW3046450854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.